Barclays
May 28, 2026
Americas Morning Research Summary
Market ReportEquitiesDerivativesFinancialsHealth Care
A comprehensive daily summary of rating changes and research highlights across the Americas, focusing on biotech initiations, bank earnings, and AI-driven infrastructure shifts.
Key Takeaways
- 1.Barclays initiated coverage on four oncology platform stocks (Alpha Tau, Cellectis, Immunome, and Sutro Biopharma) all with Overweight ratings.
- 2.Major Canadian banks (BMO, BNS, NA) reported 2Q26 results tracking toward ROE targets of 14-17% by fiscal year 2027.
- 3.Cloud security firms including CrowdStrike, Zscaler, and Cloudflare are raising CapEx guidance due to rising memory and component costs.
Table of Contents
- Summary of Changes
- Consumer
- Energy
- Financial Services
- Healthcare
- Industrials
- Internet & Media
- Retail
- Technology
- Thematic Investing
- Derivatives
Document Preview
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Andrew LazarBrian MortonLuke SergottSaket Kalia
Securities
DRTSBMO.TOCRMSNOWCRWDTSLA
Themes
AI Infrastructure ShiftOncology Platform DifferentiationPost-Earnings Estimate Revisions
Regions
North AmericaAsia PacificEuropeUnited StatesCanadaChina
